Esomeprazole and omeprazole may possibly boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) resulting in greater adverse effects including drowsiness, although the clinical relevance is lower in the majority of people – keep track of the affected person for adverse effects (e.If affected individual are not able to resume t

Esomeprazole and omeprazole may well enhance the serum concentrations of benzodiazepines (through CYP2C19 inhibition) bringing about amplified adverse effects like drowsiness, although the scientific relevance is lower in the majority of people – keep track of the affected person for adverse effects (e.If patient are unable to resume their typica